Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
MILLENNIUM PHARMACEUTICALS, INC.
CAMBRIDGE, MA US
1. 20110039820 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS 02-17-20112. 20110021544 HYDROCHLORIDE SALT OF ((1S,2S,4R)-4--2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE 01-27-2011
3. 20110020798 Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor 01-27-2011
4. 20110003807 Thiazole derivatives - compound represented by the formula or : STR00001 wherein each symbol is as defined in the specification 01-06-2011
5. 20110003806 Heteroaryls and uses thereof - This invention provides compounds of formula IA or IB: STR00001 wherein R 01-06-2011
6. 20100324093 CCR9 INHIBITORS AND METHODS OF USE THEREOF 12-23-2010
7. 20100311715 ALPHA CARBOLINES AND USES THEREOF - This invention provides alpha-carboline compounds of formula I: STR00001 wherein R 12-09-2010
8. 20100310651 SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION 12-09-2010
9. 20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses 11-18-2010
10. 20100291099 NOVEL 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 AND 32222 MOLECULES AND USES THEREFOR 11-18-2010
11. 20100280074 CCR9 INHIBITORS AND METHODS OF USE THEREOF 11-04-2010
12. 20100279313 Novel secreted immunomodulatory proteins and uses thereof 11-04-2010
13. 20100273808 LACTATE SALT OF 4-[6-METHOXY-7-(3-PIPERIDIN-1-YL-PROPOXY)QUINAZOLIN-4-YL]PIPERAZINE-1-CAR- BOXYLIC ACID(4-ISOPROPOXYPHENYL)-AMIDE AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS 10-28-2010
14. 20100256172 Heteroaryls and uses thereof - This invention provides compounds of formula I: STR00001 wherein R 10-07-2010
15. 20100234356 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS 09-16-2010
16. 20100210035 HUMAN PROTEINS RESPONSIBLE FOR NEDD8 ACTIVATION AND CONJUGATION 08-19-2010
17. 20100204180 PROTEASOME INHIBITORS - novel compounds useful as proteasome inhibitors 08-12-2010
18. 20100197924 PREPARATION OF AMINOTETRALIN COMPOUNDS - synthetic processes for preparation of aminotetralin compounds with kinase inhibitory activity 08-05-2010
19. 20100183601 Combination of Aurora Kinase Inhibitors and Anti-CD20 Antibodies 07-22-2010
20. 20100179162 Crystal forms of 4-[6-methoxy-7(3-piperidin-1-yl-propoxy) quinazoline-4yl) piperazine-1-carboxylic acid (4-isopropoxyphenyl)-amide 07-15-2010
21. 20100179126 THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: STR00001 wherein R 07-15-2010
22. 20100174072 SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS 07-08-2010
23. 20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor 06-17-2010
24. 20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor 06-03-2010
25. 20100098713 NOVEL 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 AND 65577 MOLECULES AND USES THEREFOR 04-22-2010
26. 20100093802 CCR9 INHIBITORS AND METHODS OF USE THEREOF 04-15-2010
27. 20100093713 BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE 04-15-2010
28. 20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor 04-15-2010
29. 20100086922 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment 04-08-2010
30. 20100081633 Derivatives of 1-amino-2-cyclobutylethylboronic acid 04-01-2010
31. 20100075951 Heteroaryls and uses thereof - This invention provides compounds of formula I: STR00001 wherein R 03-25-2010
32. 20100062487 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses 03-11-2010
33. 20100016289 Compounds Useful as Antagonists of CCR2 - compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R 01-21-2010
34. 20100009384 ACTR-1, a novel human acyltransferase and uses thereof 01-14-2010
35. 20090325925 Thiophenes and uses thereof - This invention provides thiophene compounds of formula I: STR00001 wherein R 12-31-2009
36. 20090325903 BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF 12-31-2009
37. 20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof 12-31-2009
38. 20090304703 Compositions and methods for the diagnosis and treatment of immune disorders 12-10-2009
39. 20090299060 COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION 12-03-2009
40. 20090286956 DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, and INTEGRIN ALPHA SUBUNIT Protein and nucleic acid molecules and uses thereof 11-19-2009
41. 20090286823 CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders 11-19-2009
42. 20090286714 Novel molecules of the card-related protein family and uses thereof 11-19-2009
43. 20090285835 Antibodies which bind human CXCR3 - Antibodies and antigen-binding fragments of antibodies that bind human CXCR3 are disclosed 11-19-2009
44. 20090280482 Novel nucleic acid sequences encoding adenylate kinases, alcohol dehydrogenases, ubiquitin proteases, lipases, adenylate cyclases, and GTPase activators 11-12-2009
45. 20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity 11-05-2009
46. 20090275050 14273 receptor, a novel G-protein coupled receptor 11-05-2009
47. 20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof 10-29-2009
48. 20090269350 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor 10-29-2009
49. 20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor 10-29-2009
50. 20090264361 Identification of a family of secreted proteins in vascular endothelium 10-22-2009
51. 20090263860 Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor 10-22-2009
52. 20090247731 BORONIC ESTER AND ACID COMPOUNDS, SYNTHESIS AND USES 10-01-2009
53. 20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor 09-10-2009
54. 20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses 09-03-2009
55. 20090208489 Antibodies That Bind OV064 and Methods of Use Therefor 08-20-2009
56. 20090197884 Compounds Useful as Antagonists of CCR2 - compounds of general formula I: or a pharmaceutically acceptable salt thereof 08-06-2009
57. 20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases 07-16-2009
58. 20090181393 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy 07-16-2009
59. 20090163497 Compounds Useful as Antagonists of CCR2 - STR00001 The present invention provides compounds of general formula or a pharmaceutically acceptable salt 06-25-2009
60. 20090148834 Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancers 06-11-2009
61. 20090137579 Mesylate salt of an IKK inhibitor - the compound of formula STR00001 or a solvate thereof or crystalline forms thereof 05-28-2009
62. 20090136961 Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancer 05-28-2009
63. 20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses 05-28-2009
64. 20090131422 Salts of an IKK inhibitor - the Tartrate Mono-Hydrochloride Malonate and p-Toluenesulfonate Salts of the compound of formula 05-21-2009
65. 20090130681 21132, a Human G-protein coupled receptor family member and uses therefor 05-21-2009
66. 20090105213 Lactam compounds useful as protein kinase inhibitors 04-23-2009
67. 20090099132 Proteasome inhibitors - novel compounds useful as proteasome inhibitors 04-16-2009
68. 20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor 03-12-2009
69. 20090054495 CCR9 inhibitors and methods of use thereof 02-26-2009
70. 20090042836 Proteasome inhibitors - novel compounds useful as proteasome inhibitors 02-12-2009
71. 20090041752 Compositions and methods for the treatment and diagnosis of immune disorders 02-12-2009
72. 20090036678 Process for the synthesis of E1 activating enzyme inhibitors 02-05-2009
73. 20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses 11-27-2008
74. 20080274472 Novel kinases and uses thereof - Novel kinase polypeptides, proteins, and nucleic acid molecules are disclosed 11-06-2008
75. 20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor 10-09-2008
76. 20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor 10-02-2008
77. 20080234468 Novel 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor 09-25-2008
78. 20080220495 DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof 09-11-2008
79. 20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses 09-04-2008